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Summary
 
Mouse germinal center (GC) B cells have been shown to undergo secondary V(D)J (V, vari-
able; D, diversity; J, joining) recombination (receptor editing) mediated by the reexpressed
products of recombination activating gene (
 
RAG
 
)
 
-1
 
 and 
 
RAG-2
 
. We show here that interleu-
kin (IL)-7 as well as IL-4 was effective in inducing functional
 
 RAG 
 
products in mouse IgD
 
1
 
 B
cells activated via CD40 in vitro. Blocking of the IL-7 receptor (IL-7R) by injecting an anti–
IL-7R monoclonal antibody resulted in a marked suppression of the reexpression of 
 
RAG-2
 
and subsequent V(D)J recombination in the draining lymph node of immunized mice, whereas
 
RAG-2
 
 expression was not impaired in immunized IL-4–deficient mice. Further, these periph-
eral B cells activated in vitro or in vivo were found to express IL-7R. These findings indicate a
novel role for IL-7 and IL-7R in inducing receptor editing in GC B cells.
Key words: recombination activating genes • mature B cells • germinal center • interleukin 7 • 
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B
 
cell antigen receptor diversity is generated by the re-
combination of three classes of germline DNA seg-
ments: variable (V),
 
1
 
 diversity (D), and joining (J) (1).
V(D)J recombination is mediated by the products of re-
combination activating gene (
 
RAG
 
)
 
-1
 
 and 
 
RAG-2 
 
during
the early stages of B cell development in the bone marrow
(2–5). In some cases, it has been reported that a V(D)J
combination thus established can be replaced by a second-
ary rearrangement during immature stages. For instance,
transgenes encoding autoantibodies were frequently re-
placed by new endogenously rearranged L and/or H chain
genes, leading to the formation of a nonautoreactive anti-
gen receptor (6–9). IgM
 
1
 
IgD
 
2
 
 
 
immature B cells isolated
from bone marrow have been shown to express 
 
RAG
 
genes and to undergo further rearrangement of L chain
genes in in vitro cultures (10–12). This secondary V(D)J re-
arrangement is termed receptor editing, and is thought to
be involved in the maintenance of self-tolerance in primary
lymphoid tissue (9). However, an established V(D)J combi-
nation in a given mature B cell clone has been thought to
be stable during differentiation in the periphery, since
 
RAG
 
 expression has been believed to be shut down in pe-
ripheral mature B cells (13, 14).
Recently, we and another group of investigators have
shown that RAG-1 and RAG-2 proteins are reexpressed in
germinal center (GC) B cells in secondary lymphoid tissues
of immunized mice (15–17). The reexpressed 
 
RAG
 
 prod-
ucts are considered to be functional as V(D)J recombinase
because recombination signal sequence breaks reflecting
the rearrangement of 
 
k
 
–L chain and H chain gene loci (18,
19) and circular DNA excision product derived from 
 
l
 
–L
chain gene rearrangement (20) have been detected in GC
B cells of immunized mice. Further, V(D)J rearrangement
was also observed in mature mouse B cells stimulated in
vitro with LPS plus IL-4 (19, 20), which is an effective
stimulus for inducing 
 
RAG
 
 expression in IgD
 
1
 
 mature
mouse B cells (15). These findings strongly suggest that GC
B cells undergo receptor editing by using reexpressed
RAG-1 and RAG-2.
GC is a microenvironment in which somatic hypermu-
tation, isotype switching, and affinity maturation of Abs are
undertaken. The somatic mutation is basically a random
 
1
 
Abbreviations used in this paper:
 
 D, diversity; FDC, follicular dendritic cell;
 
g
 
c, the 
 
g
 
 common chain of IL-7R; GC, germinal center; J, joining; RAG
or 
 
RAG
 
, recombination activating gene; RT-PCR, reverse transcriptase–
dependent PCR; V, variable.
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process, and thus considered to result in the generation of
B cell clones with unwanted (autoreactive or low affinity)
as well as high affinity antigen receptors, the former of
which may be selected negatively by apoptosis or rendered
unresponsive (5, 21). The discovery of receptor editing in
GC B cells implies the existence of a novel pathway for the
revision of unwanted B cell antigen receptors in peripheral
lymphoid tissues (22). However, the overall profile of the
pathway, including what really triggers receptor editing and
how 
 
RAG
 
 reexpression is regulated, remains to be eluci-
dated.
To examine these issues, we analyzed cytokines that are
responsible for reexpression of RAG-1 and RAG-2 in GC
B cells. As reported previously, IL-4 is effective as a cofac-
tor in inducing 
 
RAG
 
 expression in anti-CD40–stimulated
mouse splenic B cells in vitro (15). However, our prelimi-
nary experiments using IL-4–deficient mutant mice indi-
cated that IL-4 deficiency did not impair 
 
RAG
 
 expression
in draining LNs after immunization, suggesting that cyto-
kine(s) other than IL-4 are more important in the gene ex-
pression in vivo. In the present work, we show that IL-7, a
critical cofactor in bone marrow B cell development (11,
23, 24), also plays a pivotal role in inducing 
 
RAG
 
 expres-
sion and the subsequent V(D)J recombination in mouse
splenic B cells stimulated in vitro with an anti-CD40 mAb
and in GC B cells in immunized mice.
Another important finding of this study is that IL-7R
was induced in these peripheral B cells activated both in
vitro and in vivo, since IL-7R has been reported to be
present in pre-B cells, whereas B cells in later developmen-
tal stages, including pre–B-II, immature B, and mature B
cells, do not express a detectable level of IL-7R (24–26).
IL-7 has been regarded as a crucial cytokine involved in B
cell development at premature stages (24), but its function
in mature B cells has not been fully investigated. Our find-
ings suggest a novel role for IL-7 and IL-7R in the diversi-
fication and selection of B cells in GCs. These results are
discussed in terms of the striking analogy between GCs and
bone marrow as microenvironments for B cell differentia-
tion.
 
Materials and Methods
 
Cell Culture.
 
B cells were prepared by treating spleen cells
from male C3H/HeN mice (7-9 wk of age; Charles River Japan,
Kanagawa, Japan) with anti-Thy 1.2 mAb (Serotec Ltd., Kidling-
ton, UK) followed by incubation with low-toxic rabbit comple-
ment (Cedarlane Labs., Ontario, Canada), as described previously
(27). The B cells (3 
 
3
 
 10
 
6
 
/ml) were cultured with 1 
 
m
 
g/ml rat
anti–mouse CD40 mAb (LB429; Seikagaku Kogyo Co. Ltd., To-
kyo, Japan) and 10 ng/ml mouse recombinant IL-4 or IL-7 (Pep-
roTech, Inc., Princeton, NJ) for 2–3 d in 1 ml of RPMI 1640
medium containing 10% fetal bovine serum (GIBCO BRL,
Gaithersburg, MD), 10
 
2
 
5
 
 M 2-ME, 100 U/ml penicillin G, and
50 
 
m
 
g/ml streptomycin.
Other cytokines were added to the culture as follows: human
recombinant IL-2 (donated by Takeda Chemical Industry, Osaka,
Japan) at 200 U/ml; mouse recombinant IL-3, IL-6, and IL-10
and human recombinant IL-13 (PeproTech, Inc.) at 10 ng/ml;
and mouse recombinant IFN-
 
g
 
 and IL-5 (Genzyme Corp., Cam-
bridge, MA) at 100 U/ml and 50 U/ml, respectively. The level of
each cytokine tested was sufficient for exerting its typical biologi-
cal activity.
In some experiments, cultures were performed using purified
IgD
 
1
 
 splenic B cells. The IgD
 
1
 
 
 
B cells were prepared by panning
splenic B cells on anti–mouse IgD–coated culture plates as re-
ported previously (15).
 
Reverse Transcriptase–dependent PCR.
 
Total RNA was ex-
tracted from 10
 
6
 
 cells by the RNAZol B method, as described
(15). The extracted RNA preparations were reverse transcribed,
and the resultant cDNA was amplified by PCR using sense and
antisense primers 5
 
9
 
-CACATCCACAAGCAGGAAGTACAC-3
 
9
 
and 5
 
9
 
-GGTTCAGGGACATCTCCTACTAAG-3
 
9
 
 for RAG-2,
and 5
 
9
 
-CCATCACCATCTTCCAGGAG-3
 
9
 
 and 5
 
9
 
-CCTGC-
TTCACCACCTTCCTTG-3
 
9
 
 for GAPDH, respectively. Both
primer pairs spanned an intron, and did not amplify the contami-
nating genomic DNA. Time-release PCR, which heightens the
specificity of the amplification, was performed using 
 
AmpliTaq
 
Gold (Perkin-Elmer Corp., Foster City, CA) as polymerase ac-
cording to the manufacturer’s protocol. PCR was carried out for
 
RAG-2
 
 at 94
 
8
 
C for 12 min, followed by 40 cycles at 94
 
8
 
C for 1
min, 60
 
8
 
C for 1 min, and 72
 
8
 
C for 2 min; and for 
 
GAPDH
 
, 26
cycles at 94
 
8
 
C for 30 s, 60
 
8
 
C for 30 s, and 72
 
8
 
C for 30 s. These
PCR cycles were confirmed to be in the exponential phase of the
amplification. The amplified products were electrophoresed on
7.5% polyacrylamide gel and visualized by staining with SYBER
Green I (FMC Bioproducts, Rockland, ME). In some experiments,
 
RAG-2 
 
expression was estimated by reverse transcriptase–depen-
dent (RT)-PCR followed by Southern blotting as described pre-
viously (15, 17). The PstI-HindI 124-bp internal fragment of
 
RAG-2 
 
cDNA was used as a probe. 
 
RAG-2
 
 cDNA was provided
by Dr. K. Hamatani (Radiation Effects Research Foundation, Hi-
roshima, Japan).
RT-PCR analysis of other gene expression was carried out in
a similar fashion, using the following primers: 5
 
9
 
-GCCTGTCA-
CATCATCTGAGTGCC-3
 
9
 
 and 5
 
9
 
-CAGGAGGCATCCAG-
GAACTTCTG-3
 
9
 
 for IL-7, 5
 
9
 
-GAGATCATCGGCATTTTG-
AAC-3
 
9
 
 and 5
 
9
 
-CTTGGACTCATTCATGGTGCA-3
 
9
 
 for IL-4,
5
 
9
 
-CGAGTGAAATGCCTAACTC-3
 
9
 
 and 5
 
9
 
-GCGTCCAGT-
TGCTTTCAC-3
 
9
 
 for IL-7R
 
a
 
, and 5
 
9
 
-GGAGCTCCAAGG-
TCCTCATGT-3
 
9
 
 and 5
 
9
 
-TAGCTTCTGTACAGCTCGCCT-3
 
9
 
for the 
 
g
 
 common chain of IL-7R (
 
g
 
c).
 
Detection of DNA Excision Product Derived from V
 
l
 
1-J
 
l
 
1 Rear-
rangement. 
 
10
 
6
 
 cells that had been cultured with anti-CD40
mAb/IL-7 for 4 d or isolated from the draining LN on day 7 after
immunization were suspended in 200 
 
m
 
l of the lysis buffer con-
taining 10 mM Tris-HCl (pH 8.0), 10 mM KCl, 1.5 mM MgCl
 
2
 
,
0.5% Tween 20, and 0.1 mg/ml Proteinase K. The suspension
was incubated at 56
 
8
 
C for 45 min and 95
 
8
 
C for 10 min. The su-
pernatant was then directly analyzed for circular V
 
l
 
1-J
 
l
 
1 exci-
sion product by PCR. PCR amplification (28–32 cycles) was
performed using 
 
AmpliTaq
 
 Gold as polymerase and primers
which span the signal joint (6), 5
 
9
 
-GCTGCATACATCACA-
GATGC-3
 
9
 
 and 5
 
9
 
-CAATGATTCTATGTTGTGCC-3
 
9
 
. Each
cycle consisted of 94
 
8
 
C for 30 s, 62
 
8
 
C for 30 s, and 72
 
8
 
C for 90 s.
The amplified products were electrophoresed and visualized by
Southern blotting using a 
 
32
 
P-labeled probe, which is the Hind-
III-NspI 183-bp fragment derived from a DNA segment of the
V
 
l
 
1-J
 
l
 
1 excision product (provided by Dr. D. Nemazee, Na-
tional Jewish Medical and Research Center, Denver, CO).
Exon 4 of the 
 
g-actin gene was amplified as an internal control
using the primer pair 59-ATGTTTGAAACCTTCAATAC-39367 Hikida et al.
and 59-GGAAGGAAGGCTGGAAGAGT-39. The amplified prod-
uct was visualized by staining with SYBER Green I.
Flow Cytometric Analysis. Cultured B cells (106) were incu-
bated with rabbit anti–mouse IL-7Ra (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA) and rat anti–mouse IgD mAb (Cosmo
Bio Co. Ltd., Tokyo, Japan) at 48C for 30 min, followed by
staining with FITC-labeled goat anti–rabbit IgG (Sigma Chemi-
cal Co., St. Louis, MO), PE-labeled goat anti–rat IgG (PharMin-
gen, San Diego, CA), and cychrome-labeled mAb to B220
(PharMingen). Each Ab was added at 10 mg/ml. Flow cytometric
analysis was performed by FACSCaliburÒ (Becton Dickinson,
San Jose, CA). An irrelevant rabbit IgG did not give positive re-
sults.
Immunization and Administration of IL-7R–blocking Ab. IL-4–
deficient BALB/c mice (28) were maintained in the facility at Ki-
tasato University. Male C3H/HeN mice or female wild-type or
IL-4–deficient BALB/c mice were immunized in each hind foot-
pad with 20 mg of TNP-KLH and 0.45 mg of alum in 20 ml sa-
line. On days 6–8 after immunization, popliteal LN cells were ex-
amined for expression of various genes. For blocking IL-7Ra in
vivo, 1 mg of rat anti–mouse IL-7Ra mAb derived from a hybrid-
oma A7R34 established by S.-I. Nishikawa and colleagues (29)
was injected intraperitoneally on days 0, 2, and 4 after immuniza-
tion. It was confirmed in an in vitro experiment that 1:1,000 di-
luted A7R34 ascites completely suppressed RAG-2 expression in
anti-CD40–stimulated splenic B cells in the presence of 10 ng/ml
IL-7. Control mice received the same amount of rat IgG purified
from normal rat serum.
Immunohistochemical Analysis of Draining LNs. On day 8 after
immunization, popliteal LNs were excised and subjected to im-
munohistochemical analysis. For immunofluorescent staining of
LN sections, 8-mm-thick cryosections mounted onto slides were
allowed to air-dry for 20 min and were fixed in ice-cold acetone
for 10 min. Rehydration and preblocking were performed as de-
scribed previously (15). A buffer containing 10 mM Tris (pH
8.0), 150 mM NaCl, 0.05% Tween 20, and 1% BSA (30) was
used for diluting Abs and for washing. The slides were treated for
1 h with the following three combinations of first Abs: (a) biotin-
ylated rabbit anti–mouse IL-7 (Santa Cruz Biotechnology, Inc.)
and rat anti–mouse follicular dendritic cell (FDC) mAb, FDC-M1;
(b) biotinylated rat mAb GL-7 and rabbit anti–mouse IL-7Ra;
and (c) FITC-conjugated rabbit anti–mouse IL-7Ra and biotiny-
lated rabbit anti–RAG-1 (PharMingen). After washing thoroughly,
a and b slides were reacted for 40 min with rhodaminated avidin
(Sigma Chemical Co.), and FITC-conjugated goat anti–rat IgG
(Organon Teknika-Cappel, Durham, NC) and rhodaminated avi-
din and FITC-conjugated goat anti–rabbit IgG, respectively. A c
slide was treated with rhodaminated avidin alone. Each Ab was
added at 5 mg/ml. Rhodaminated avidin was used at 2 mg/ml.
FDC-M1 and GL-7 mAbs were provided by Dr. M.H. Kosco-
Vilbois (Geneva Biomedical Research Institute, Geneva, Switzer-
land) and Dr. K.S. Hathcock (National Institutes of Health, Be-
thesda, MD), respectively. The slides were finally mounted with
low fluorescent glycerol and coverslip protection, and were ob-
served with a confocal laser scanning microscope (Bio-Rad Labo-
ratories, Hercules, CA). Specificity of each immunolabeling was
confirmed using irrelevant control Abs.
Results and Discussion
IL-7 as a Cofactor for the Expression of RAG Genes in Anti-
CD40–stimulated Mouse Splenic B Cells In Vitro. To ana-
lyze cytokines involved in the reexpression of RAG genes
in peripheral B cells, a series of cytokines was tested for
their potency to induce gene expression in mouse splenic B
cells cultured with an anti-CD40 mAb in vitro. The ex-
pression of RAG-2 transcripts was assessed by RT-PCR af-
ter culture for 2 or 3 d. As reported previously (15), IL-4
was effective in inducing the expression of RAG-2 in this
culture system (Fig. 1 A). Among cytokines tested other
than IL-4, IL-7 was also an effective cofactor for RAG-2
expression. This is worth noting because IL-7 has been re-
ported to be critical for B cell development in bone mar-
row (24), but its function in peripheral B cells has not been
fully elucidated. IL-7–dependent RAG-2 expression was
reproducible in at least seven repeated experiments, in
which  RAG-2 expression usually peaked on day 3 of cul-
ture. IL-2, IL-5, and IL-13 were not effective under the
same experimental conditions (Fig. 1 A), and neither were
IL-3, IL-6, IL-10, and IFN-g (data not shown).
A combination of IL-7 and anti-CD40 was required to
induce RAG-2 expression, since neither IL-7 nor anti-
CD40 alone was active (Fig. 1 B). It was also confirmed
(data not shown) that (a) the concentrations of IL-4 and IL-7
used in the experiment shown in Fig. 1 were optimal for
RAG-2 expression; (b) a combination of IL-7 and IL-4 at
their optimal doses did not further enhance RAG-2 expres-
sion; and (c) RAG-1 was also expressed in parallel with
RAG-2 in B cells stimulated with anti-CD40/IL-7.
IL-7–induced RAG Products Are Functional as V(D)J Re-
combinase. In a previous report, we showed that RAG
gene products expressed in LPS/IL-4–stimulated splenic B
cells mediated de novo Vl1-Jl1 rearrangement in l–L
chain genes (20). Therefore, it was investigated whether
IL-7–induced RAG products are also functional as a V(D)J
recombinase. Circular DNA excision product derived from
Vl1-Jl1 rearrangement was amplified by PCR using prim-
ers spanning the signal joint, and the amplified product was
detected by Southern blotting (Fig. 2). The excision prod-
uct was observed in splenic B cells stimulated with anti-
Figure 1. IL-7 as a cofactor for reex-
pression of RAG-2 in mouse splenic B cells
stimulated with anti-CD40 mAb in vitro.
(A) Splenic B cells from C3H/HeN mice
(3 3 106/ml) were cultured with 1 mg/ml
anti-CD40 mAb (LB429) in the presence
or absence of IL-7 (10 ng/ml), IL-4 (10
ng/ml), and other indicated cytokines for 2
or 3 d. RAG-2 expression was assessed by RT-PCR. Mouse thymocytes were used as a positive control. (B) Dependence of RAG-2 expression on
both IL-7 and anti-CD40. The B cells were cultured as indicated for 3 d.368 Role of IL-7 in Receptor Editing
CD40/IL-7, but was negligible in unstimulated cells and in
cells stimulated with anti-CD40 alone. Thus, RAG gene
products induced by anti-CD40/IL-7 are thought to have
potency to mediate V(D)J recombination.
It has been reported that signal joint formation in the ex-
cision product generates a restriction site cleavable with
ApaLI (Fig. 2; reference 31). ApaLI was found to cleave the
PCR-amplified product (302 bp) into two fragments at the
expected site, thus confirming the identity of the amplified
product (data not shown). It has been reported that signal
joint formation is a relatively slow process and requires cell
cycle progression (32). It is possible that the circular DNA
excision product observed in anti-CD40/IL-7–stimulated
B cells is not generated by the mere joining of the signal
breaks produced during premature stages, since stimulation
with LPS alone, which causes the cell cycle to progress but
fails to induce RAG expression, did not produce the exci-
sion product in these B cells, as reported previously (20).
Expression of RAG-2 and IL-7R in IgD1 Mature B Cells
Stimulated with Anti-CD40/IL-7 In Vitro. The effectiveness
of IL-7 in inducing RAG expression in mouse splenic B
cells is surprising because it has been reported that B cells in
later developmental stages, including late pre–B-II, imma-
ture, and mature B cells, lose responsiveness to IL-7 due to
downregulation of IL-7R (24, 26). We have verified that
surface IgD1 mature mouse B cells express RAG genes
when they are stimulated with LPS/IL-4 in vitro (15).
Since IL-7 is a growth factor of premature B cells (24, 25),
it was important to determine whether the IL-7–induced
RAG-2 expression and Vl1-Jl1 rearrangement observed
in splenic B cells (Figs. 1 and 2) occurred in mature B cells,
or whether RAG expression was due to the outgrowth of
premature B cells that might have been present in the B
cell preparation. For this purpose, similar experiments to
those shown in Fig. 1 were performed using purified IgD1
mature B cells. The IgD1 B cells (.99% pure as assessed by
flow cytometry) prepared by panning splenic B cells on anti-
IgD–coated culture plates were found to express RAG-2
when stimulated with anti–CD40/IL-7 in vitro (Fig. 3 A),
indicating that activated mature mouse B cells can express
the RAG gene in response to IL-7.
Since mature B cells have been reported to express no
detectable level of IL-7R (25, 26), IgD1 B cells may have
to regain IL-7R to express RAG-2 transcripts in response
to exogenous IL-7. Interestingly, the following findings
show that this is the case. RT-PCR analysis showed that
the purified IgD1 B cells cultured without stimuli did not
express a detectable level of the a chain of IL-7R (IL-
7Ra), whereas stimulation with anti-CD40 plus IL-7 re-
sulted in the induction of an appreciable level of IL-7Ra
(Fig. 3 A). A slight expression of IL-7Ra was observed
when cells were stimulated with anti-CD40 alone. gc, an-
other subunit of IL-7R (24), was also found to be ex-
pressed in the IL-7Ra1 cells, suggesting the formation of
functional IL-7R. Further, consistent with the RT-PCR
analysis shown in Fig. 3 A, flow cytometric analysis re-
vealed that a majority of the IgD1 B cells became positive
for IL-7Ra after stimulation with anti-CD40/IL-7 (Fig. 3
Figure 2. Vl1-Jl1 rearrange-
ment in mouse splenic B cells
stimulated with anti-CD40
mAb plus IL-7. B cells were cul-
tured by themselves or with anti-
CD40 alone or anti-CD40 plus
IL-7 for 4 d. Circular DNA ex-
cision product derived from
Vl1-Jl1 rearrangement was am-
plified by PCR using the de-
picted primers for 28, 30, or 32
reaction cycles, and visualized by
Southern blotting.
Figure 3. Expression of RAG-
2, IL-7Ra, and gc in purified
IgD1 mature B cells. (A) Purified
IgD1 B cells prepared by pan-
ning splenic B cells on anti-IgD–
coated culture plates were stimu-
lated with anti-CD40/IL-7 for
3  d, followed by assessment of
the expression of the indicated
genes by RT-PCR. Purity of the
IgD1 B cell preparation was
confirmed by flow cytometry.
(B) The purified IgD1 B cells
were analyzed for expression of
immunoreactive IL-7Ra before
and after stimulation with anti-
CD40/IL-7 for 3 d.369 Hikida et al.
B). Taken together, our observations indicate that IL-7 can
act as a potent cofactor for inducing RAG expression via
IL-7R in activated mature B cells.
Role of IL-7 in RAG Expression in GC B Cells In Vivo.
Does IL-7 also mediate RAG expression in vivo in a similar
fashion? As shown in Fig. 4, transcripts of IL-7, IL-4, and
RAG-2 were induced on days 6 and 8 after immunization
in popliteal LN cells from mice immunized in the footpad,
whereas these transcripts were not detected in LN cells on
day 0. Under the same experimental conditions, the DNA
excision product derived from Vl1-Jl1 rearrangement was
found to be generated in GCs in parallel with RAG-2 ex-
pression, as reported previously (20).
Immunohistochemical analysis of popliteal LNs on day 8
after immunization showed that the majority of IL-7–con-
taining cells costained with an mAb to FDC, suggesting
that FDCs are a major source of IL-7 in the LN (Fig. 5 A).
Another interesting observation is that a population of GL-7
mAb–reactive cells that represent GC B cells (33) was posi-
tive for immunoreactive IL-7Ra (Fig. 5 B). It has been re-
ported that CD41 T cells are also present in the light zone
of GCs (33). Thus, GC B cells may be able to receive the
signals necessary for RAG expression from FDCs and/or
CD41 T cells.
We have shown by immunohistochemical analysis that
RAG-1 and RAG-2 proteins are expressed in GC B cells
in popliteal LNs after immunization (15, 17). Other inves-
tigators have detected RAG-mediated generation of re-
combination signal sequence breaks in GL-71 GC B cells
(18, 19). Expression of RAG-1 was again confirmed in the
present experiment. An important observation was that the
RAG-1 molecules visualized with rhodamine (red fluores-
cence) were present in IL-7Ra1 cells labeled with FITC
(green fluorescence; Fig. 5 C), suggesting that a population
of GL-71 GC B cells regains IL-7R and subsequently ex-
presses RAG proteins in response to IL-7, the majority of
Figure 4. Expression of IL-7,
IL-4, and RAG-2 transcripts in
draining LN cells in immunized
mice. C3H/HeN mice were im-
munized with TNP-KLH/alum
in their footpads. Expression of
IL-7, IL-4, and RAG-2 tran-
scripts was assessed by RT-PCR
in popliteal LN cells on days 0, 6, and 8 after immunization. Mouse thy-
mocytes (T) were used as a positive control for RAG-2 expression.
Figure 5. Immunohistochemical analysis of the ex-
pression of IL-7, IL-7Ra, and RAG-1 in GCs of
draining LNs. C3H/HeN mice were immunized in
each hind footpad with TNP-KLH/alum, and cryosec-
tions of popliteal LNs were prepared on day 8 after im-
munization. They were double-labeled with (A) FDC-
specific mAb and polyclonal anti–IL-7, (B) polyclonal
anti–IL-7Ra and GL-7 mAb, or (C) polyclonal anti–
IL-7Ra and anti–RAG-1. FDC and IL-7Ra were vi-
sualized with FITC (green), and IL-7, GL-7, and RAG-1
were visualized with rhodamine (red) as described in
Materials and Methods. Each FITC and rhodamine im-
age and superimposition of the two are shown in A and
B. C, A superimposed image of IL-7Ra and RAG-1.
Costaining with FITC and rhodamine gave orange-
yellow fluorescence. Original magnification 3100.370 Role of IL-7 in Receptor Editing
which may be supplied from FDCs. It has been reported
that IL-7 was detected in human tonsillar FDCs, and ton-
sillar B cells have been shown to proliferate in response to
IL-7 (34). However, expression of IL-7R on these B cells
has not been directly demonstrated. Although IL-7R has not
been detected in immature and mature mouse B cells (24–26),
IgD1 mature B cells stimulated in vitro with anti-CD40/
IL-7 were shown to express IL-7R (Fig. 3). To our knowl-
edge, this is the first documented report describing reex-
pression of IL-7R on peripheral B cells in vitro and in vivo.
IL-7R–dependent Receptor Editing in GCs.  As described
above, both IL-4 and IL-7 proved effective for inducing
RAG-2 expression in vitro (Fig. 1). Are IL-7 and IL-4
equally responsible for RAG expression in vivo? Experi-
ments using mutant mice with a disrupted IL-4 gene re-
vealed that IL-4 depletion did not impair expression of
RAG-2 in draining LNs of immunized mutant mice (Fig. 6
A), suggesting that the IL-4 deficiency was compensated
for by other cofactor(s), including IL-7. In addition, IL-4
deficiency did not affect GC formation in draining LNs af-
ter immunization (data not shown). However, an auxiliary
or compensatory role for IL-4 cannot be ruled out. For in-
stance, we observed that IL-4 was as effective as IL-7 in
upregulating IL-7Ra in B cells activated in vitro via
CD40, suggesting that IL-4 enhances responsiveness of GC
B cells to IL-7 (our unpublished observations).
IL-7– and IL-7R–deficient mice are inappropriate for
analyzing the role of IL-7 in RAG expression in vivo, since
the generation of mature B cells is impaired in these mice
(24). Therefore, we used an anti–IL-7Ra mAb (A7R34)
that has been shown to block signaling by IL-7 (29). A group
of mice immunized with TNP-KLH/alum in their foot-
pads was injected intraperitoneally with the anti–IL-7Ra
mAb on days 0, 2, and 4 after immunization, and the
popliteal LN cells were examined for expression of RAG-2
on day 7. Interestingly, RAG-2 expression and subsequent
Vl1-Jl1 rearrangement in popliteal LN cells were mark-
edly suppressed in mice treated with anti–IL-7Ra mAb
compared with those receiving control Ab (Fig. 6 B).
These results and the observations made in the in vitro ex-
periments (Figs. 1–3) strongly suggest that IL-7 plays a piv-
otal role in inducing receptor editing in GC B cells. How-
ever, the participation of other IL-7R ligands cannot be
ruled out, since it has been reported that the IL-7Ra chain
binds another ligand, thymic stroma–derived lymphopoi-
etin (35).
The following experiments were performed to confirm
that inhibition of RAG-2 expression by anti–IL-7Ra treat-
Figure 6. Analysis of cytokines involved in RAG-2 ex-
pression in vivo in draining LNs of immunized mice. (A)
RAG-2 expression was not impaired in IL-4–deficient
mice. Wild-type or IL-4–deficient BALB/c mice (n 5 3)
were immunized in their footpads with TNP-KLH/alum.
On day 7 after immunization, pooled popliteal LN cells
from each group were assessed for expression of RAG-2 by
RT-PCR. (B) Suppression of RAG-2 expression and
Vl1-Jl1 rearrangement in draining LNs of immunized
mice by injection of anti–IL-7Ra mAb (A7R34). C3H/
HeN mice (n 5 2) were immunized in their footpads with
TNP-KLH/alum, then injected intraperitoneally with 1 mg/d anti–IL-7Ra mAb or rat IgG on days 0, 2, and 4 after immunization. The pooled popliteal
LN cells were examined for expression of RAG-2 and excision product derived from Vl1-Jl1 rearrangement on day 7 after immunization, by RT-
PCR/Southern blotting and PCR/Southern blotting, respectively. PCR was performed with the varying reaction cycles indicated. Bone marrow cells
(BM) were used as a positive control.
Figure 7. GC formation in draining LNs of anti–IL-7Ra–treated immunized mice. Control and anti–IL-7Ra–treated C3H/HeN mice (n 5 2) used
in Fig. 6 B were analyzed for GC formation in popliteal LNs. (A) GC formation was assessed by staining fixed cryosections of LNs with FITC–peanut ag-
glutinin as described previously (reference 17). A representative image of a GC from each group of mice is shown (original magnification 3100). (B) The
number of viable cells per LN (an average of three LNs) and the T to B cell ratio in the LN cells are shown. Flow cytometric analysis was performed by
staining the LN cells with PE-labeled anti-B220 and FITC-labeled anti-CD3 (Sigma Chemical Co.).371 Hikida et al.
ment is a specific result of suppressed lymphopoiesis (Fig.
7). The size and number of GCs in the LNs were his-
tochemically comparable between control and anti–IL-7Ra–
treated mice examined in Fig. 6 B (data not shown). A rep-
resentative microscopic image of a GC from each group of
mice is shown (Fig. 7 A). The number of cells in the
popliteal LNs usually increased by 8–10-fold on day 7 after
immunization in the footpad. Treatment of mice with
anti–IL-7Ra mAb resulted in neither a reduction in the
number of viable cells nor a significant change in T to B
cell ratio in LNs on day 7 after immunization (Fig. 7 B).
Further, anti-TNP IgM and IgG1 Ab responses in anti–IL-
7Ra–treated mice were at least 80% as high as those ob-
served in control mice (data not shown). Thus, blockade of
IL-7R by mAb may specifically suppress the GC reaction
under our experimental conditions. Taking these data to-
gether, the use of anti–IL-7Ra mAb can be considered ad-
vantageous for analyzing the physiological role of reex-
pressed  RAG  products.
It has been shown that IL-7 enhances the rearrangement
of the T cell receptor b locus in cultured mouse thy-
mocytes by sustaining RAG expression (36), whereas the
involvement of IL-7 in B cell development appears to be
more complicated. IL-7 has been shown to stimulate the
rearrangement at the H chain locus in cultured pre-B cells
in the initial phase (24, 25, 37). However, the persistent
presence of IL-7 in culture inhibited the subsequent rear-
rangement of the L chain locus. Conversely, removing IL-7
from the culture resulted in an increase in RAG expression
that allowed the cells to undergo L chain gene rearrange-
ment (11, 25). In contrast, we found that IL-7 was effective
in inducing RAG expression and the subsequent rearrange-
ment at the l–L chain locus in mature B cells, suggesting
that IL-7 acts on premature and mature B cells in a differ-
ent way.
It has been pointed out that GCs as primary lymphoid
tissue resemble bone marrow, in that molecules characteris-
tically expressed in bone marrow B cells, including RAG
proteins (15, 16), l5 surrogate L chain (18), the heat-stable
antigen, Fas, and IL-7, are shared by GC B cells (21, 33).
The observation that B cells restore responsiveness to IL-7
in GCs further supports the striking analogy between GCs
and bone marrow as microenvironments for B cell devel-
opment.
In conclusion, these findings and those of previous reports
(18–20) show that a V(D)J combination can be secondarily
rearranged by reexpressed RAG-1 and RAG-2 proteins in
GCs. IL-7 and IL-7R are considered to play a pivotal role
in inducing RAG expression. A plausible role for reex-
pressed  RAG products is to revise unwanted antigen recep-
tors that may be generated during somatic hypermutations
in GC B cells. Such GC B cell clones may move the differ-
entiation process upstream to an IL-7–responsive prema-
ture phenotype and enter the receptor editing pathway.
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